Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 3488-3497

  Furi, Leonardo ^a   Ciusa, Maria Laura ^a   Knight, Daniel ^b   Di Lorenzo, Valeria ^a,b   Tocci, Nadia ^a   Cirasol, Daniela ^a,c   Aragones, Lluis ^d   Coelho, Joana Rosado ^e   Freitas, Ana Teresa ^e   Marchi, Emmanuela ^f   Moce, Laura ^d   Visa, Pilar ^d   Northwood, John Blackman ^b   Viti, Carlo ^f   Borghi, Elisa ^c   Orefici, Graziella ^g   Morrissey, Ian ^b   Oggioni, Marco Rinaldo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Quotient Bioresearch Ltd   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d Eurofins Medinet Inc   (Germany)

^e INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^f UNIVERSITY OF FLORENCE   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; BACTERIAL PROTEIN; BENZALKONIUM CHLORIDE; BIOCIDE; BISBIGUANIDE DERIVATIVE; CHLORHEXIDINE; ETHIDIUM BROMIDE; NORA PROTEIN; QACA PROTEIN; QACB PROTEIN; QACC PROTEIN; QACG PROTEIN; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; EFFUSION; GALLERIA MELLONELLA; IN VITRO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PUMP; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BENZALKONIUM COMPOUNDS; CHLORHEXIDINE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOTHS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PHENOTYPE; PROMOTER REGIONS, GENETIC; QUATERNARY AMMONIUM COMPOUNDS; SERIAL PASSAGE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84880261721     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00498-13     Document Type: Article

References (41)

1. European Parliament and Council. 1998. Directive 98/8/EC concerning the placing of biocidal products on the market. Official J. Eur. Commun. L 123:1-63.
2. Oggioni MR, Furi L, Coelho JR, Maillard JY, Martinez JL. 2013. Recent advances in the potential interconnection between antimicrobial resistance to biocides and antibiotics. Expert Rev. Anti Infect. Ther. 11:363-366.
3. Poole K. 2002. Mechanisms of bacterial biocide and antibiotic resistance. Symp. Ser. Soc. Appl. Microbiol. 31:55S-64S.
4. Russell AD. 2003. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect. Dis. 3:794-803.
5. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martínez-Solano L, Sánchez MB. 2009. A global view of antibiotic resistance. FEMS Microbiol. Rev. 33:44-65.
6. Patel D, Kosmidis C, Seo SM, Kaatz GW. 2010. Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 54:5070-5073.
7. Poole K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.
8. Yoshida H, Bogaki M, Nakamura S, Ubukata K, Konno M. 1990. Characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.
9. Ng EY, Trucksis M, Hooper DC. 1994. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 38:1345-1355.
10. Kaatz GW, Thyagarajan RV, Seo SM. 2005. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob. Agents Chemother. 49:161-169.
11. Huet AA, Raygada JL, Mandiratta K, Seo SM, Kaatz GW. 2008. Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes. Microbiology 154:3144-3153.
12. DeMarco CE, Cushing LA, Frempong-Manso E, Seo SM, Jaravaza TA, Kaatz GW. 2007. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 51:3235-3239.
13. Littlejohn TG, Paulsen IT, Gillespie MT, Tennent JM, Midgley M, Jones IG, Purewal AS, Skurray RA. 1992. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 74:259-265.
14. Paulsen IT, Brown MH, Dunstan SJ, Skurray RA. 1995. Molecular characterization of the staphylococcal multidrug resistance export protein QacC. J. Bacteriol. 177:2827-2833.
15. Paulsen IT, Brown MH, Littlejohn TG, Mitchell BA, Skurray RA. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. U. S. A. 93:3630-3635.
16. Heir E, Sundheim G, Holck AL. 1998. The Staphylococcus qacH gene product: a new member of the SMR family encoding multidrug resistance. FEMS Microbiol. Lett. 163:49-56.
17. Heir E, Sundheim G, Holck AL. 1999. The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry. J. Appl. Microbiol. 86:378-388.
18. Bjorland J, Steinum T, Sunde M, Waage S, Heir E. 2003. Novel plasmidborne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius. Antimicrob. Agents Chemother. 47:3046-3052.
19. Alam MM, Kobayashi N, Uehara N, Watanabe N. 2003. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 9:109-121.
20. Russell AD, Suller MT, Maillard JY. 1999. Do antiseptics and disinfectants select for antibiotic resistance?. J. Med. Microbiol. 48:613-615.
21. Maillard JY, Denver SP. 2009. Emerging bacterial resistance following biocide exposure: should we be concerned?. Chim. Oggi. 27:26-28.
22. Ciusa ML, Furi L, Knight D, Decorosi F, Fondi M, Raggi C, Coelho JR, Aragones L, Moce L, Visa P, Freitas AT, Baldassarri L, Fani R, Viti C, Orefici G, Martinez JL, Morrissey I, Oggioni MR. 2012. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. Int. J. Antimicrob. Agents 40:210-220.
23. Coelho JR, Carrico JA, Knight D, Martinez JL, Morrissey I, Oggioni MR, Freitas AT. 2013. The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus. PLoS One 8:e55582. doi:10.1371/journal.pone.0055582.
24. Tocci N, Iannelli F, Bidossi A, Ciusa ML, Decorosi F, Viti C, Pozzi G, Ricci S, Oggioni MR. 2013. Functional analysis of pneumococcal drug efflux pumps associates the MATE DinF transporter with quinolone susceptibility. Antimicrob. Agents Chemother. 57:248-253.
25. Arioli S, Elli M, Ricci G, Mora D. 2013. Assessment of the susceptibility of lactic acid bacteria to biocides. Int. J. Food Microbiol. 163:1-5.
26. Oggioni MR, Ciusa ML, Furi L, Baldassarri L, Orefici G, Cirasola D, Martinez JL, Morrissey I, Borghi E. 2012. Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan. Antimicrob. Agents Chemother. 56:6068-6069.
27. Hernandez A, Ruiz FM, Romero A, Martinez JL. 2011. The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog. 7:e1002103. doi:10.1371/journal.ppat.1002103.
28. CLSI. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed. M7-A8. CLSI, Wayne, PA.
29. NCCLS. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. M26-A. CLSI, Wayne, PA.
30. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
31. European Committee for Standardisation. 2010. EN 1276:2009/AC: 2010. Chemical disinfectants and antiseptics-quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas-test method and requirements (phase 2, step 1). European Committee for Standardisation, Brussels, Belgium.
32. Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC, Jr, Eliopoulos GM. 2009. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J. Infect. Dis. 199:532-536.
33. Schmitz FJ, Hertel B, Hofmann B, Scheuring S, Verhoef J, Fluit AC, Heinz HP, Köhrer K, Jones ME. 1998. Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J. Antimicrob. Chemother. 42:561-563.
34. European Committee for Standardization. 1997. European standard EN 1276. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of the bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic, and institutional areas-test method and requirements (phase 2, step 1). European Committee for Standardisation, Brussels, Belgium.
35. Maillard JY. 2010. Emergence of bacterial resistance to microbiocides and antibiotics. Microbiol. Australia 31:159-165.
36. Mayer S, Boos M, Beyer A, Fluit AC. 2001. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and-susceptible European isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 47:896-897.
37. Smith K, Gemmell CG, Hunter IS. 2008. The association between biocide tolerance and the presence or absence of qac genes among hospitalacquired and community-acquired MRSA isolates. J. Antimicrob. Chemother. 61:78-84.
38. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Osterlund A, Rodloff A, Steinbakk M, Urbaskova P, Vatopoulos A. 2003. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 52:145-148.
39. Holt DC, Holden MT, Tong SY, Castillo-Ramirez S, Clarke L, Quail MA, Currie BJ, Parkhill J, Bentley SD, Feil EJ, Giffard PM. 2011. A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol. Evol. 3:881-895.
40. Shearer JE, Wireman J, Hostetler J, Forberger H, Borman J, Gill J, Sanchez S, Mankin A, LaMarre J, Lindsay JA, Bayles K, Nicholson A, O'Brien F, Jensen SO, Firth N, Skurray RA, Summers AO. 2011. Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci. G3 1:581-591.
41. Latimer J, Forbes S, McBain AJ. 2012. Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan. Antimicrob. Agents Chemother. 56:3092-3100.